FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2080189763> ?p ?o ?g. }

• W2080189763 endingPage "54" @default.
• W2080189763 startingPage "51" @default.
• W2080189763 abstract "Objectives To examine the distribution and outcomes of recurrent disease in patients with ovarian, fallopian tube and peritoneal cancers after optimal cytoreduction and adjuvant intraperitoneal (IP) chemotherapy. Methods All patients diagnosed with ovarian, fallopian tube, or peritoneal cancer between 2004 and 2009 who underwent optimal cytoreductive surgery and received adjuvant intravenous (IV) and IP chemotherapy with paclitaxel and a platinum-based agent were eligible. Age, performance status, tumor origin, stage, and grade were recorded. First recurrences were identified using CA125 values, radiographic studies, operative notes, and pathology reports. Sites of recurrence were classified as intraperitoneal (IP), extraperitoneal (EP) or distant. Kaplan–Meier estimates and Cox multivariate regression models were used to assess the associations between recurrent disease distribution and progression-free survival (PFS) and overall survival (OS). Results One hundred forty-three patients met the criteria for inclusion. The majority were Stage III (86%) and serous histology (77%). Eighty-four (58.7%) received IV/IP paclitaxel/cisplatin per GOG-172 and 59 (41.3%) received IV/IP paclitaxel/carboplatin. Seventy-two percent completed 6 cycles. Ninety (62.9%) patients manifested a recurrence. One-hundred twelve sites of recurrence were identified with 70 (62.5%) IP and 42 (37.5%) EP and distant sites. Nineteen (21%) recurred in more than one site, i.e. both IP and EP locations. Site of recurrence did not impact OS, however, patients who recurred in multiples sites had significantly worse OS (p<0.001). Conclusion Approximately 40% of patients treated with IP chemotherapy have a first recurrence outside the peritoneal cavity. Though site of recurrence did not affect OS those with multi-focal recurrence demonstrate worse survival." @default.
• W2080189763 created "2016-06-24" @default.
• W2080189763 creator A5019240868 @default.
• W2080189763 creator A5027422738 @default.
• W2080189763 creator A5030257115 @default.
• W2080189763 creator A5037937774 @default.
• W2080189763 creator A5053081492 @default.
• W2080189763 creator A5089158382 @default.
• W2080189763 date "2012-10-01" @default.
• W2080189763 modified "2023-10-18" @default.
• W2080189763 title "Patterns of recurrence in advanced epithelial ovarian, fallopian tube and peritoneal cancers treated with intraperitoneal chemotherapy" @default.
• W2080189763 cites W1565276921 @default.
• W2080189763 cites W1922469696 @default.
• W2080189763 cites W1969942245 @default.
• W2080189763 cites W1998258610 @default.
• W2080189763 cites W2038328856 @default.
• W2080189763 cites W2088446746 @default.
• W2080189763 cites W2124439343 @default.
• W2080189763 cites W2154175915 @default.
• W2080189763 cites W2316501478 @default.
• W2080189763 doi "https://doi.org/10.1016/j.ygyno.2012.05.026" @default.
• W2080189763 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22659193" @default.
• W2080189763 hasPublicationYear "2012" @default.
• W2080189763 type Work @default.
• W2080189763 sameAs 2080189763 @default.
• W2080189763 citedByCount "23" @default.
• W2080189763 countsByYear W20801897632013 @default.
• W2080189763 countsByYear W20801897632014 @default.
• W2080189763 countsByYear W20801897632015 @default.
• W2080189763 countsByYear W20801897632016 @default.
• W2080189763 countsByYear W20801897632017 @default.
• W2080189763 countsByYear W20801897632018 @default.
• W2080189763 countsByYear W20801897632019 @default.
• W2080189763 countsByYear W20801897632020 @default.
• W2080189763 countsByYear W20801897632021 @default.
• W2080189763 countsByYear W20801897632022 @default.
• W2080189763 countsByYear W20801897632023 @default.
• W2080189763 crossrefType "journal-article" @default.
• W2080189763 hasAuthorship W2080189763A5019240868 @default.
• W2080189763 hasAuthorship W2080189763A5027422738 @default.
• W2080189763 hasAuthorship W2080189763A5030257115 @default.
• W2080189763 hasAuthorship W2080189763A5037937774 @default.
• W2080189763 hasAuthorship W2080189763A5053081492 @default.
• W2080189763 hasAuthorship W2080189763A5089158382 @default.
• W2080189763 hasConcept C121608353 @default.
• W2080189763 hasConcept C126322002 @default.
• W2080189763 hasConcept C126894567 @default.
• W2080189763 hasConcept C141071460 @default.
• W2080189763 hasConcept C143998085 @default.
• W2080189763 hasConcept C146357865 @default.
• W2080189763 hasConcept C150173356 @default.
• W2080189763 hasConcept C151730666 @default.
• W2080189763 hasConcept C2775883341 @default.
• W2080189763 hasConcept C2776694085 @default.
• W2080189763 hasConcept C2777249960 @default.
• W2080189763 hasConcept C2777292972 @default.
• W2080189763 hasConcept C2778239845 @default.
• W2080189763 hasConcept C2780427987 @default.
• W2080189763 hasConcept C2780435969 @default.
• W2080189763 hasConcept C2781451048 @default.
• W2080189763 hasConcept C71924100 @default.
• W2080189763 hasConcept C86803240 @default.
• W2080189763 hasConcept C90924648 @default.
• W2080189763 hasConceptScore W2080189763C121608353 @default.
• W2080189763 hasConceptScore W2080189763C126322002 @default.
• W2080189763 hasConceptScore W2080189763C126894567 @default.
• W2080189763 hasConceptScore W2080189763C141071460 @default.
• W2080189763 hasConceptScore W2080189763C143998085 @default.
• W2080189763 hasConceptScore W2080189763C146357865 @default.
• W2080189763 hasConceptScore W2080189763C150173356 @default.
• W2080189763 hasConceptScore W2080189763C151730666 @default.
• W2080189763 hasConceptScore W2080189763C2775883341 @default.
• W2080189763 hasConceptScore W2080189763C2776694085 @default.
• W2080189763 hasConceptScore W2080189763C2777249960 @default.
• W2080189763 hasConceptScore W2080189763C2777292972 @default.
• W2080189763 hasConceptScore W2080189763C2778239845 @default.
• W2080189763 hasConceptScore W2080189763C2780427987 @default.
• W2080189763 hasConceptScore W2080189763C2780435969 @default.
• W2080189763 hasConceptScore W2080189763C2781451048 @default.
• W2080189763 hasConceptScore W2080189763C71924100 @default.
• W2080189763 hasConceptScore W2080189763C86803240 @default.
• W2080189763 hasConceptScore W2080189763C90924648 @default.
• W2080189763 hasIssue "1" @default.
• W2080189763 hasLocation W20801897631 @default.
• W2080189763 hasLocation W20801897632 @default.
• W2080189763 hasOpenAccess W2080189763 @default.
• W2080189763 hasPrimaryLocation W20801897631 @default.
• W2080189763 hasRelatedWork W1502181122 @default.
• W2080189763 hasRelatedWork W2026580852 @default.
• W2080189763 hasRelatedWork W2039658173 @default.
• W2080189763 hasRelatedWork W2280856801 @default.
• W2080189763 hasRelatedWork W2311734504 @default.
• W2080189763 hasRelatedWork W2380099415 @default.
• W2080189763 hasRelatedWork W2419075599 @default.
• W2080189763 hasRelatedWork W248568554 @default.
• W2080189763 hasRelatedWork W3015616220 @default.
• W2080189763 hasRelatedWork W4250038123 @default.
• W2080189763 hasVolume "127" @default.

• next